A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/10/2004	CN1543956A Compound paracetamol and chlorphenamine maleate slow releasing tablet and its preparation
11/10/2004	CN1543955A Freeze-dried dipyrimadole preparation for injection and prepartion thereof
11/10/2004	CN1543954A Tablet with controlled release of alfuzosine chlorhydrate
11/10/2004	CN1543953A Colon targeted fluorouracil minipills prepartion
11/10/2004	CN1543952A Enoxacin ocular sustained release gelata and preparation thereof
11/10/2004	CN1543951A Hydroxycamptothecin inhalant powder and fog preparition
11/10/2004	CN1543950A Hydroxyzine hydrochloride dripping pills and preparation thereof
11/10/2004	CN1543949A Dripping pills of isopropiram fumaratis and its preparation
11/10/2004	CN1543948A Amlodipine and nifedipine medicinal composition
11/10/2004	CN1543947A Novel use of indomethacin and its external applied preparation for treating cutaneous pruritus
11/10/2004	CN1543946A Oral preparation of Tegaserod or its acid salt and its preparing process
11/10/2004	CN1543945A Medicine and technique for monomer extraction from psoralea fruit
11/10/2004	CN1543944A Dripping pills with silybin
11/10/2004	CN1543943A Oral silybin sustained release agent and preparation thereof
11/10/2004	CN1543942A Haw leaf general flavone soft capsule and preparation thereof
11/10/2004	CN1543941A Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
11/10/2004	CN1543940A Medicine for prevention and treatment of osteoporosis by red sage root and water extract thereof
11/10/2004	CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof
11/10/2004	CN1543938A Atenolol guttate pill and method for preparing the same
11/10/2004	CN1543937A Metformin hydrochloride sustained-release tablet and method for preparing the same
11/10/2004	CN1543936A Sibutramine hydrochloride guttate pill
11/10/2004	CN1543935A Tulobuterol hydrochloride guttate pill and method for preparing the same
11/10/2004	CN1543934A Ambroxol guttate pill and method for preparing the same
11/10/2004	CN1543933A Curcumin injection and method for preparing the same
11/10/2004	CN1543929A Ultrafine fibre preparation of taxol and method and apparatus for preparing the same
11/10/2004	CN1543859A Use of ligustilide for prevention and treatment of atherosclerosis
11/10/2004	CN1175106C Human insulin recombinant gene, preparation method and application
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174991C O form crystal of clarithromycin
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174980C Imidazole pyridine derivatives capable of inhibiting gastric acid secretion
11/10/2004	CN1174979C Piperazine and piperidine compounds
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/10/2004	CN1174977C Pseudo polymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174972C Method for production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or 2-keto-L-gulonate esters
11/10/2004	CN1174971C Morpholine ethers
11/10/2004	CN1174969C New preparation method for N-(1, 1-dimethyl ethide)-4-[[(5'-oxethyl-4-cis-[2-(4-morpholino) oxethyl]-2'-oxo ancylus [cyclohexane-1, 3'-[3H] indole]-1'(2'H) group)-sulfonyl]-3-methoxyl benzamide and it
11/10/2004	CN1174964C Vitamin D3 Analogs
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174770C External medicine for curing gynaecological inflammation and its preparing method
11/10/2004	CN1174763C Medicine for treating digestive ulcer
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174752C 核糖口服液 Oral ribose
11/10/2004	CN1174751C Method for preventing and curing skid aging
11/10/2004	CN1174750C Concentrated granular medicine for treating baby's cough and asthma and its preparing process
11/10/2004	CN1174749C Tanshinone nanometer preparation and its preparing method
11/10/2004	CN1174748C New use of docetaxel for treating hepatoma
11/10/2004	CN1174747C Liquid antiacid compositions
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/10/2004	CN1174744C Thermal formed solid releasing-controlled medicinal composition
11/10/2004	CN1174741C Surface modified particulate compositions of biologically active substances
11/10/2004	CN1174740C Taste masked pharmaceutical liquid formulations
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815555 Substituted phenol compounds useful for anesthesia and sedation
11/09/2004	US6815542 Nucleoside compounds and uses thereof
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815531 For diagnosis/therapy of autoimmune diseases; antitumor agents; drugs; cytotoxic t-lymphocytes
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815464 Halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate derivatives; analgesics
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815462 Anticarcinogenic, viricidal, and fungicidal agents; water solubility
11/09/2004	US6815461 Method of inhibiting retroviral integrase
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815457 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin e-2,4-dione, maleic acid salt in polymorphic form
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/09/2004	US6815454 Percutaneously applicable preparation and suppository containing an antidementia medicament
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815450 Axon regeneration with PKC inhibitors
11/09/2004	US6815447 N-type calcium channel antagonists for the treatment of pain
11/09/2004	US6815443 5-Amino-1-pentene-3-ol substituted derivatives
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815436 Hyperglycemic agents; antidiabetic agents
11/09/2004	US6815435 Pharmaceutical compositions containing DDS compounds
11/09/2004	US6815434 Administering otoprotectant glutathione peroxidase mimic (ebselen), xanthine oxidase inhibitor (allopurinol), and glutathione precursor (n-acetylcysteine)
11/09/2004	US6815433 Composition and method for the treatment of dysglucaemia
11/09/2004	US6815429 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/09/2004	US6815428 Pyrazole derivatives and diabetic medicine containing them
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815187 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
11/09/2004	US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004	US6814987 Compositions and methods of use for extracts of magnoliaceae plants
11/09/2004	US6814986 Composition for treating obesity and esthetic treatment process
11/09/2004	US6814983 Specific formulations of vitamins and minerals for supplementing those with high physiological stress levels such as during pregnancy and lactation
11/09/2004	US6814981 Ganglioside immunostimulating complexes and uses thereof
11/09/2004	US6814978 Process for preparing a soft tablet
11/09/2004	US6814977 Fenofibrate, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-propanoic acid, 1-methylethylester, having enhanced bioavailability when compared to commercially available formulations
11/09/2004	US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
11/09/2004	US6814972 Composition for prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814966 Monoclonal or polyclonal antibody which inhibits or antangonizes tnf- alpha, such as infliximab, thereby treating the subject with glaucoma

1 ... 4899 4900 4901 4902 4903 4904 4905 4906 4907 4908 4909 4910 4911 4912 4913 4914 4915 4916 4917 4918 4919 ... 7860